Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy

Fig. 5

IBM nomograms for OS (a) and PFS (b). The constructed IBM nomograms were used to estimate OS and PFS for individual OSCC patients. IBM, imaging biomarker; OS, overall survival; PFS, progression-free survival; GLCM, grey level co-occurrence matrices; NGTDM, neighbourhood grey-tone difference matrices; GLSZM, grey level size-zone matrices

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us